KSHV MicroRNAs repress tropomyosin 1 and increase anchorage-independent growth and endothelial tube formation

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Kieffer Kwon, Philippe ^a   Happel, Christine ^a   Uldrick, Thomas S ^a   Ramalingam, Dhivya ^a   Ziegelbauer, Joseph M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TROPOMYOSIN; MICRORNA; MICRORNA K2; MICRORNA K5; UNCLASSIFIED DRUG; VASCULOTROPIN A; 3' UNTRANSLATED REGION; ISOPROTEIN; MESSENGER RNA; TPM1 PROTEIN, HUMAN; TROPOMYOSIN; VIRUS RNA;

3' UNTRANSLATED REGION; ANOIKIS; ARTICLE; BINDING SITE; CELL FUNCTION; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE LOSS; GENE TARGETING; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; KAPOSI SARCOMA; MICROARRAY ANALYSIS; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; PROTEIN TARGETING; PROTEOMICS; UMBILICAL VEIN ENDOTHELIAL CELL; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; GENE ORDER; GENETICS; METABOLISM; MOLECULAR WEIGHT; RNA INTERFERENCE; VIROLOGY;

3' UNTRANSLATED REGIONS; ANOIKIS; CELL LINE; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GENE ORDER; HERPESVIRUS 8, HUMAN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICRORNAS; MOLECULAR WEIGHT; PROTEIN ISOFORMS; RNA INTERFERENCE; RNA, MESSENGER; RNA, VIRAL; TROPOMYOSIN;

EID: 84942436795     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135560     Document Type: Article

References (66)

1. Martin JN. The epidemiology of KSHV and its association with malignant disease. 2007. Epub 2011/02/25. NBK47381 [bookaccession]. PMID: 21348075.
2. Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, et al. Risk factors for Kaposi'ssarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer. 1998; 77(4):543-8. Epub 1998/07/29. doi: 10.1002/(SICI)1097-0215(19980812) 77:4<543::AID-IJC12>3.0.CO;2-7 [pii]. PMID: 9679756.
3. Goudsmit J, Renwick N, Dukers NH, Coutinho RA, Heisterkamp S, Bakker M, et al. Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73. Proc Natl Acad Sci U S A. 2000; 97(9):4838-43. Epub 2000/04/26. 97/9/4838 [pii]. PMID: 10781089; PubMed Central PMCID: PMC18319.
4. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998; 338(14):948-54. Epub 1998/04/02. doi: 10.1056/NEJM199804023381403 PMID: 9521982.
5. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesviruslike DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995; 332 (18):1186-91. Epub 1995/05/04. doi: 10.1056/NEJM199505043321802 PMID: 7700311.
6. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi's sarcomaassociated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995; 86 (4):1276-80. Epub 1995/08/15. PMID: 7632932.
7. Guilluy C, Zhang Z, Bhende PM, Sharek L, Wang L, Burridge K, et al. Latent KSHV infection increases the vascular permeability of human endothelial cells. Blood. 2011; 118(19):5344-54. Epub 2011/09/02. blood-2011-03-341552 [pii] doi: 10.1182/blood-2011-03-341552 PMID: 21881052; PubMed Central PMCID: PMC3217415.
8. Wang L, Damania B. Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res. 2008; 68(12):4640-8. Epub 2008/06/19. 68/12/4640 [pii] doi: 10.1158/0008-5472.CAN-07-5988 PMID: 18559509; PubMed Central PMCID: PMC2612117.
9. Umbach JL, Cullen BR. In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery. J Virol. 2010; 84 (2):695-703. Epub 2009/11/06. JVI.02013-09 [pii] doi: 10.1128/JVI.02013-09 PMID: 19889781; PubMed Central PMCID: PMC2798371.
10. Ziegelbauer JM. Functions of Kaposi's sarcoma-associated herpesvirus microRNAs. Biochim Biophys Acta. 2011; 1809(11-12):623-30. Epub 2011/05/28. S1874-9399(11)00070-8 [pii] doi: 10.1016/j. bbagrm.2011.05.003 PMID: 21616184; PubMed Central PMCID: PMC3174279.
11. Liang D, Lin X, Lan K. Looking at Kaposi's Sarcoma-Associated Herpesvirus-Host Interactions from a microRNA Viewpoint. Front Microbiol. 2011; 2:271. Epub 2012/01/26. doi: 10.3389/fmicb.2011.00271 PMID: 22275910; PubMed Central PMCID: PMC3258008.
12. Ramalingam D, Kieffer-Kwon P, Ziegelbauer JM. Emerging Themes from EBV and KSHV microRNA Targets. Viruses. 2012; 4(9):1687-710. doi: 10.3390/v4091687 PMID: 23170179
13. Sharma-Walia N, Naranatt PP, Krishnan HH, Zeng L, Chandran B. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements. J Virol. 2004; 78(8):4207-23. Epub 2004/03/30. PMID: 15047836; PubMed Central PMCID: PMC374261.
14. Carroll PA, Brazeau E, Lagunoff M. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology. 2004; 328(1):7-18. Epub 2004/09/24. doi: 10. 1016/j.virol.2004.07.008 S0042-6822(04)00479-9 [pii]. PMID: 15380353; PubMed Central PMCID: PMC3147029.
15. Cheng F, Pekkonen P, Laurinavicius S, Sugiyama N, Henderson S, Gunther T, et al. KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelialto-mesenchymal transition. Cell Host Microbe. 2011; 10(6):577-90. Epub 2011/12/20. S1931-3128(11) 00364-7 [pii] doi: 10.1016/j.chom.2011.10.011 PMID: 22177562.
16. Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, et al. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe. 2011; 10(5):515-26. Epub 2011/11/22. doi: 10.1016/j.chom.2011.09.012 PMID: 22100165; PubMed Central PMCID: PMC3222872.
17. Gooding C, Smith CW. Tropomyosin exons as models for alternative splicing. Adv Exp Med Biol. 2008; 644:27-42. Epub 2009/02/13. PMID: 19209811.
18. Lin JJ, Eppinga RD, Warren KS, McCrae KR. Human tropomyosin isoforms in the regulation of cytoskeleton functions. Adv Exp Med Biol. 2008; 644:201-22. Epub 2009/02/13. PMID: 19209824.
19. Franzen B, Linder S, Uryu K, Alaiya AA, Hirano T, Kato H, et al. Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br J Cancer. 1996; 73(7):909-13. Epub 1996/04/01. PMID: 8611405; PubMed Central PMCID: PMC2074270.
20. Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, et al. Two differentially expressed genes in normal human prostate tissue and in carcinoma. Cancer Res. 1996; 56(16):3634-7. Epub 1996/08/15. PMID: 8705997.
21. Hughes JA, Cooke-Yarborough CM, Chadwick NC, Schevzov G, Arbuckle SM, Gunning P, et al. Highmolecular-weight tropomyosins localize to the contractile rings of dividing CNS cells but are absent from malignant pediatric and adult CNS tumors. Glia. 2003; 42(1):25-35. Epub 2003/02/21. doi: 10. 1002/glia.10174 PMID: 12594734.
22. Takenaga K, Nakamura Y, Sakiyama S. Differential expression of a tropomyosin isoform in low-and high-metastatic Lewis lung carcinoma cells. Mol Cell Biol. 1988; 8(9):3934-7. Epub 1988/09/01. PMID: 3221870; PubMed Central PMCID: PMC365453.
23. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res. 2009; 15(12):3998-4008. Epub 2009/06/11. 1078-0432.CCR-08-3053 [pii] doi: 10.1158/1078-0432.CCR-08-3053 PMID: 19509158.
24. Helfman DM, Flynn P, Khan P, Saeed A. Tropomyosin as a regulator of cancer cell transformation. Adv Exp Med Biol. 2008; 644:124-31. Epub 2009/02/13. PMID: 19209818.
25. Raval GN, Bharadwaj S, Levine EA, Willingham MC, Geary RL, Kute T, et al. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene. 2003; 22(40):6194-203. Epub 2003/09/19. doi: 10.1038/sj.onc.1206719 1206719 [pii]. PMID: 13679858.
26. Mahadev K, Raval G, Bharadwaj S, Willingham MC, Lange EM, Vonderhaar B, et al. Suppression of the transformed phenotype of breast cancer by tropomyosin-1. Exp Cell Res. 2002; 279(1):40-51. Epub 2002/09/06. S0014482702955837 [pii]. PMID: 12213212.
27. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem. 2007; 282(19):14328-36. Epub 2007/03/17. M611393200 [pii] doi: 10.1074/jbc. M611393200 PMID: 17363372.
28. Wang M, Li W, Chang GQ, Ye CS, Ou JS, Li XX, et al. MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler Thromb Vasc Biol. 2011; 31(9):2044-53. Epub 2011/08/06. ATVBAHA.111.229559 [pii] doi: 10.1161/ATVBAHA.111.229559 PMID: 21817107.
29. Zhang JC, Claffey K, Sakthivel R, Darzynkiewicz Z, Shaw DE, Leal J, et al. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J. 2000; 14(15):2589-600. Epub 2000/12/02. doi: 10.1096/fj.99-1025com 14/15/2589 [pii]. PMID: 11099478.
30. Zhang JC, Donate F, Qi X, Ziats NP, Juarez JC, Mazar AP, et al. The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin. Proc Natl Acad Sci U S A. 2002; 99(19):12224-9. Epub 2002/08/28. doi: 10.1073/pnas.192668299 192668299 [pii]. PMID: 12196635; PubMed Central PMCID: PMC129426.
31. Donate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, et al. Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities. Cancer Res. 2004; 64(16):5812-7. Epub 2004/08/18. doi: 10.1158/0008-5472.CAN-04-0440 64/16/5812 [pii]. PMID: 15313924.
32. Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, et al. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion. J Cell Biochem. 2003; 89(1):133-43. Epub 2003/04/12. doi: 10. 1002/jcb.10489 PMID: 12682914.
33. MacDonald NJ, Shivers WY, Narum DL, Plum SM, Wingard JN, Fuhrmann SR, et al. Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin. J Biol Chem. 2001; 276 (27):25190-6. Epub 2001/05/04. doi: 10.1074/jbc.M100743200 M100743200 [pii]. PMID: 11335715.
34. Donate F, McCrae K, Shaw DE, Mazar AP. Extracellular tropomyosin: a novel common pathway target for anti-angiogenic therapy. Curr Cancer Drug Targets. 2004; 4(7):543-53. Epub 2004/12/08. PMID: 15578912.
35. Herndier BG, Werner A, Arnstein P, Abbey NW, Demartis F, Cohen RL, et al. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS. 1994; 8(5):575-81. Epub 1994/05/01. PMID: 7520247.
36. Vieira J, O'Hearn PM. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology. 2004; 325(2):225-40. Epub 2004/07/13. doi: 10.1016/j. virol.2004.03.049 PMID: 15246263.
37. Gottwein E, Cullen BR. A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J Virol. 2010; 84(10):5229-37. Epub 2010/03/12. JVI.00202-10 [pii] doi: 10. 1128/JVI.00202-10 PMID: 20219912; PubMed Central PMCID: PMC2863803.
38. Abend JR, Uldrick T, Ziegelbauer JM. Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J Virol. 2010; 84 (23):12139-51. Epub 2010/09/17. JVI.00884-10 [pii] doi: 10.1128/JVI.00884-10 PMID: 20844036; PubMed Central PMCID: PMC2976403.
39. Bruneel A, Labas V, Mailloux A, Sharma S, Vinh J, Vaubourdolle M, et al. Proteomic study of human umbilical vein endothelial cells in culture. Proteomics. 2003; 3(5):714-23. Epub 2003/05/16. doi: 10. 1002/pmic.200300409 PMID: 12748950.
40. Bruneel A, Labas V, Mailloux A, Sharma S, Royer N, Vinh J, et al. Proteomics of human umbilical vein endothelial cells applied to etoposide-induced apoptosis. Proteomics. 2005; 5(15):3876-84. Epub 2005/09/01. doi: 10.1002/pmic.200401239 PMID: 16130169.
41. Ziegelbauer JM, Sullivan CS, Ganem D. Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat Genet. 2009; 41(1):130-4. Epub 2008/12/23. ng.266 [pii] doi: 10.1038/ng.266 PMID: 19098914; PubMed Central PMCID: PMC2749995.
42. Gallaher AM, Das S, Xiao Z, Andresson T, Kieffer-Kwon P, Happel C, et al. Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis. PLoS Pathog. 2013; 9(9):e1003584. Epub 2013/09/17. doi: 10.1371/journal.ppat.1003584 PPATHOGENS-D-13-00319 [pii]. PMID: 24039573; PubMed Central PMCID: PMC3764211.
43. Wang CL, Coluccio LM. New insights into the regulation of the actin cytoskeleton by tropomyosin. Int Rev Cell Mol Biol. 2010; 281:91-128. Epub 2010/05/13. S1937-6448(10)81003-2 [pii] doi: 10.1016/S1937-6448(10)81003-2 PMID: 20460184; PubMed Central PMCID: PMC2923581.
44. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008; 36(Database issue):D154-8. Epub 2007/11/10. gkm952 [pii] doi: 10.1093/nar/gkm952 PMID: 17991681; PubMed Central PMCID: PMC2238936.
45. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature medicine. 1996; 2(3):342-6. Epub 1996/03/01. PMID: 8612236.
46. Thomson DW, Bracken CP, Szubert JM, Goodall GJ. On measuring miRNAs after transient transfection of mimics or antisense inhibitors. PloS one. 2013; 8(1):e55214. Epub 2013/01/30. doi: 10.1371/journal.pone.0055214 PMID: 23358900; PubMed Central PMCID: PMC3554668.
47. Crawford JB, Patton JG. Activation of alpha-tropomyosin exon 2 is regulated by the SR protein 9G8 and heterogeneous nuclear ribonucleoproteins H and F. Mol Cell Biol. 2006; 26(23):8791-802. Epub 2006/09/27. doi: 10.1128/MCB.01677-06 PMID: 17000773; PubMed Central PMCID: PMC1636816.
48. Lin JC, Tarn WY. Exon selection in alpha-tropomyosin mRNA is regulated by the antagonistic action of RBM4 and PTB. Mol Cell Biol. 2005; 25(22):10111-21. Epub 2005/11/02. doi: 10.1128/MCB.25.22. 10111-10121.2005 PMID: 16260624; PubMed Central PMCID: PMC1280272.
49. Meredith JE Jr., Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell. 1993; 4(9):953-61. Epub 1993/09/01. PMID: 8257797; PubMed Central PMCID: PMC275725.
50. Ma Z, Liu Z, Myers DP, Terada LS. Mechanotransduction and anoikis: death and the homeless cell. Cell Cycle. 2008; 7(16):2462-5. Epub 2008/08/23. 6463 [pii]. PMID: 18719379; PubMed Central PMCID: PMC2730734.
51. Cooper JA. Actin dynamics: tropomyosin provides stability. Curr Biol. 2002; 12(15):R523-5. Epub 2002/08/15. S096098220201028X [pii]. PMID: 12176375.
52. Efklidou S, Bailey R, Field N, Noursadeghi M, Collins MK. vFLIP from KSHV inhibits anoikis of primary endothelial cells. J Cell Sci. 2008; 121(Pt 4):450-7. Epub 2008/01/24. jcs.022343 [pii] doi: 10.1242/jcs. 022343 PMID: 18211958.
53. Guan X, Juarez JC, Qi X, Shipulina NV, Shaw DE, Morgan WT, et al. Histidine-proline rich glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells. Thromb Haemost. 2004; 92(2):403-12. Epub 2004/07/23. doi: 10.1267/THRO04080403 04080403 [pii]. PMID: 15269838.
54. Suffert G, Malterer G, Hausser J, Viiliainen J, Fender A, Contrant M, et al. Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis. PLoS pathogens. 2011; 7(12):e1002405. Epub 2011/12/17. doi: 10.1371/journal.ppat.1002405 PMID: 22174674; PubMed Central PMCID: PMC3234232.
55. Qian LW, Xie J, Ye F, Gao SJ. Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases. J Virol. 2007; 81(13):7001-10. Epub 2007/04/20. JVI.00016-07 [pii] doi: 10.1128/JVI.00016-07 PMID: 17442715; PubMed Central PMCID: PMC1933284.
56. Mansouri M, Rose PP, Moses AV, Fruh K. Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus. J Virol. 2008; 82(19):9615-28. Epub 2008/08/01. JVI.02633-07 [pii] doi: 10.1128/JVI.02633-07 PMID: 18667499; PubMed Central PMCID: PMC2546942.
57. Bharadwaj S, Thanawala R, Bon G, Falcioni R, Prasad GL. Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion. Oncogene. 2005; 24(56):8291-303. Epub 2005/09/20. 1208993 [pii] doi: 10.1038/sj.onc.1208993 PMID: 16170368.
58. Choi C, Kim D, Kim S, Jeong S, Song E, Helfman DM. From skeletal muscle to cancer: insights learned elucidating the function of tropomyosin. Journal of structural biology. 2012; 177(1):63-9. Epub 2011/11/29. doi: 10.1016/j.jsb.2011.11.016 PMID: 22119848.
59. Varga AE, Stourman NV, Zheng Q, Safina AF, Quan L, Li X, et al. Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-beta. Oncogene. 2005; 24(32):5043-52. Epub 2005/05/18. doi: 10.1038/sj.onc.1208688 PMID: 15897890.
60. Marquitz AR, Mathur A, Shair KH, Raab-Traub N. Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression. Proc Natl Acad Sci U S A. 2012; 109(24):9593-8. Epub 2012/06/01. doi: 10.1073/pnas.1202910109 PMID: 22647604; PubMed Central PMCID: PMC3386136.
61. Samols MA, Skalsky RL, Maldonado AM, Riva A, Lopez MC, Baker HV, et al. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS pathogens. 2007; 3(5):e65. Epub 2007/05/16. doi: 10.1371/journal.ppat.0030065 PMID: 17500590; PubMed Central PMCID: PMC1876501.
62. Bridge G, Monteiro R, Henderson S, Emuss V, Lagos D, Georgopoulou D, et al. The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood. 2012. doi: 10.1182/blood-2012-04-423004
63. Schevzov G, Whittaker SP, Fath T, Lin JJ, Gunning PW. Tropomyosin isoforms and reagents. Bioarchitecture. 2011; 1(4):135-64. Epub 2011/11/10. doi: 10.4161/bioa.1.4.17897 1949-0992-1-4-1 [pii]. PMID: 22069507; PubMed Central PMCID: PMC3210517.
64. Naranatt PP, Akula SM, Zien CA, Krishnan HH, Chandran B. Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. J Virol. 2003; 77(2):1524-39. Epub 2002/12/28. PMID: 12502866; PubMed Central PMCID: PMC140802.
65. Jalilian I, Heu C, Cheng H, Freittag H, Desouza M, Stehn JR, et al. Cell elasticity is regulated by the tropomyosin isoform composition of the actin cytoskeleton. PLoS One. 2015; 10(5):e0126214. Epub 2015/05/16. doi: 10.1371/journal.pone.0126214 PONE-D-15-07600 [pii]. PMID: 25978408; PubMed Central PMCID: PMC4433179.
66. Gupton SL, Anderson KL, Kole TP, Fischer RS, Ponti A, Hitchcock-DeGregori SE, et al. Cell migration without a lamellipodium: translation of actin dynamics into cell movement mediated by tropomyosin. J Cell Biol. 2005; 168(4):619-31. Epub 2005/02/18. jcb.200406063 [pii] doi: 10.1083/jcb.200406063 PMID: 15716379; PubMed Central PMCID: PMC2171771.